263 related articles for article (PubMed ID: 22151739)
1. Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.
Singh A; Wang H; Silva LC; Na C; Prieto M; Futerman AH; Luberto C; Del Poeta M
Cell Microbiol; 2012 Apr; 14(4):500-16. PubMed ID: 22151739
[TBL] [Abstract][Full Text] [Related]
2. Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans.
Raj S; Nazemidashtarjandi S; Kim J; Joffe L; Zhang X; Singh A; Mor V; Desmarini D; Djordjevic J; Raleigh DP; Rodrigues ML; London E; Del Poeta M; Farnoud AM
Biochim Biophys Acta Biomembr; 2017 Nov; 1859(11):2224-2233. PubMed ID: 28865794
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane transporter expression regulated by the glucosylceramide pathway in Cryptococcus neoformans.
Singh A; Rella A; Schwacke J; Vacchi-Suzzi C; Luberto C; Del Poeta M
BMC Res Notes; 2015 Nov; 8():681. PubMed ID: 26572681
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of the Aspergillus nidulans glucosylceramide pathway reveals that LCB Δ8-desaturation and C9-methylation are relevant to filamentous growth, lipid raft localization and Psd1 defensin activity.
Fernandes CM; de Castro PA; Singh A; Fonseca FL; Pereira MD; Vila TV; Atella GC; Rozental S; Savoldi M; Del Poeta M; Goldman GH; Kurtenbach E
Mol Microbiol; 2016 Nov; 102(3):488-505. PubMed ID: 27479571
[TBL] [Abstract][Full Text] [Related]
5. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.
Rittershaus PC; Kechichian TB; Allegood JC; Merrill AH; Hennig M; Luberto C; Del Poeta M
J Clin Invest; 2006 Jun; 116(6):1651-9. PubMed ID: 16741577
[TBL] [Abstract][Full Text] [Related]
6. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice.
Kechichian TB; Shea J; Del Poeta M
Infect Immun; 2007 Oct; 75(10):4792-8. PubMed ID: 17664261
[TBL] [Abstract][Full Text] [Related]
7. Surface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungal.
Rhome R; Singh A; Kechichian T; Drago M; Morace G; Luberto C; Del Poeta M
PLoS One; 2011 Jan; 6(1):e15572. PubMed ID: 21283686
[TBL] [Abstract][Full Text] [Related]
8. The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system.
Shea JM; Kechichian TB; Luberto C; Del Poeta M
Infect Immun; 2006 Oct; 74(10):5977-88. PubMed ID: 16988277
[TBL] [Abstract][Full Text] [Related]
9. Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.
Mor V; Farnoud AM; Singh A; Rella A; Tanno H; Ishii K; Kawakami K; Sato T; Del Poeta M
PLoS One; 2016; 11(4):e0153853. PubMed ID: 27082428
[TBL] [Abstract][Full Text] [Related]
10. Identification of fungal sphingolipid C9-methyltransferases by phylogenetic profiling.
Ternes P; Sperling P; Albrecht S; Franke S; Cregg JM; Warnecke D; Heinz E
J Biol Chem; 2006 Mar; 281(9):5582-92. PubMed ID: 16339149
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal functions of Cryptococcus neoformans copper homeostasis machinery during pulmonary infection and meningoencephalitis.
Sun TS; Ju X; Gao HL; Wang T; Thiele DJ; Li JY; Wang ZY; Ding C
Nat Commun; 2014 Nov; 5():5550. PubMed ID: 25417972
[TBL] [Abstract][Full Text] [Related]
12. Sterylglucoside catabolism in Cryptococcus neoformans with endoglycoceramidase-related protein 2 (EGCrP2), the first steryl-β-glucosidase identified in fungi.
Watanabe T; Ito T; Goda HM; Ishibashi Y; Miyamoto T; Ikeda K; Taguchi R; Okino N; Ito M
J Biol Chem; 2015 Jan; 290(2):1005-19. PubMed ID: 25361768
[TBL] [Abstract][Full Text] [Related]
13. Erg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans.
Oliveira FFM; Paes HC; Peconick LDF; Fonseca FL; Marina CLF; Bocca AL; Homem-de-Mello M; Rodrigues ML; Albuquerque P; Nicola AM; Alspaugh JA; Felipe MSS; Fernandes L
Fungal Genet Biol; 2020 Jul; 140():103368. PubMed ID: 32201128
[TBL] [Abstract][Full Text] [Related]
14. Role of host sphingosine kinase 1 in the lung response against Cryptococcosis.
McQuiston T; Luberto C; Del Poeta M
Infect Immun; 2010 May; 78(5):2342-52. PubMed ID: 20194596
[TBL] [Abstract][Full Text] [Related]
15. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease.
Vu K; Tham R; Uhrig JP; Thompson GR; Na Pombejra S; Jamklang M; Bautos JM; Gelli A
mBio; 2014 Jun; 5(3):e01101-14. PubMed ID: 24895304
[TBL] [Abstract][Full Text] [Related]
16. Cryptococcal virulence: beyond the usual suspects.
Mitchell AP
J Clin Invest; 2006 Jun; 116(6):1481-3. PubMed ID: 16741574
[TBL] [Abstract][Full Text] [Related]
17. The Granuloma Response Controlling Cryptococcosis in Mice Depends on the Sphingosine Kinase 1-Sphingosine 1-Phosphate Pathway.
Farnoud AM; Bryan AM; Kechichian T; Luberto C; Del Poeta M
Infect Immun; 2015 Jul; 83(7):2705-13. PubMed ID: 25895971
[TBL] [Abstract][Full Text] [Related]
18. Core
Thak EJ; Lee SB; Xu-Vanpala S; Lee DJ; Chung SY; Bahn YS; Oh DB; Shinohara ML; Kang HA
mBio; 2020 May; 11(3):. PubMed ID: 32398313
[No Abstract] [Full Text] [Related]
19. Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1).
Ishibashi Y; Ikeda K; Sakaguchi K; Okino N; Taguchi R; Ito M
J Biol Chem; 2012 Jan; 287(1):368-381. PubMed ID: 22072709
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipid C-9 methyltransferases are important for growth and virulence but not for sensitivity to antifungal plant defensins in Fusarium graminearum.
Ramamoorthy V; Cahoon EB; Thokala M; Kaur J; Li J; Shah DM
Eukaryot Cell; 2009 Feb; 8(2):217-29. PubMed ID: 19028992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
